C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
10/2011
10/25/2011	CA2374505C Methods for display of heterodimeric proteins on filamentous phage using pvii and pix, compositions, vectors and combinatorial libraries
10/20/2011	WO2011128247A1 N-terminal hpv e7 fusion proteins
10/20/2011	WO2011127580A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	WO2011084685A3 Saposin-a derived peptides and uses thereof
10/20/2011	WO2011084523A3 Ulk1 compositions, inhibitors, screening and methods of use
10/20/2011	US20110257375 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates
10/20/2011	US20110256569 Complex of a chaperone with beta-amyloid and methods employing this complex
10/20/2011	US20110256172 Epitope-targeted anthrax vaccine
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256091 Antibody-Targeted Cytokines for Therapy
10/20/2011	US20110256088 Targeted delivery of nucleic acids
10/20/2011	US20110256053 Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
10/20/2011	CA2796215A1 Compositions and methods for brain delivery of analgesic peptides
10/19/2011	EP2377879A1 N-terminal HPV E7 fusion proteins
10/19/2011	EP2376534A1 Sparc binding scfcs
10/19/2011	EP2231706B1 Biokinetics of fast-clearing polypeptides
10/19/2011	CN102220256A Yeast expression system for expressing HAS-Vmip-II fusion protein and construction method thereof
10/19/2011	CN102219860A FGFR-Fc fusion protein and applications thereof
10/19/2011	CN102219859A Fusion protein for antagonizing angiogenesis inducible factor and application thereof
10/19/2011	CN102219858A Cryptosporidium parvum CTL multi-epitope gene and fusion protein and application thereof
10/18/2011	US8039233 Nucleic acid sequences and their use in methods to identify umami modulatiors
10/18/2011	CA2465156C Il-21 antagonists
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/18/2011	CA2323572C Vertebrate patched-2 protein
10/13/2011	WO2011126811A2 High level expression of recombinant toxin proteins
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	WO2011063235A3 Peptides, devices, and methods for the detection of ehrlichia antibodies
10/13/2011	WO2011060242A3 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
10/13/2011	US20110252487 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250223 Hybrid and tandem expression of neisserial proteins
10/13/2011	US20110250215 Structurally-related relaxin-fusion proteins with extended in vivo half-lives
10/13/2011	US20110250174 Stable immunogenic product comprising antigenic heterocomplexes
10/13/2011	CA2793978A1 High level expression of recombinant toxin proteins
10/12/2011	EP2374894A2 A method for producing influenza hemagglutinin multivalent vaccines
10/12/2011	EP2374891A2 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374872A2 A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/12/2011	EP2373694A1 Novel semi-synthetic glycopeptides as antibacterial agents
10/12/2011	EP2373679A2 Mini-hepcidin peptides and methods of using thereof
10/12/2011	CN102216454A Fusion collagenase to which affinity tag is attached, and method for producing same
10/12/2011	CN102212141A Fusion protein TAT-NANOG, and encoding gene and application thereof
10/12/2011	CN102212140A Preparation of VEGF165 (vascular endothelial growth factor 165) analogue
10/12/2011	CN102212139A Fusion protein of tick-borne encephalitis virus envelop E protein and human antibody Fc fragment, and application thereof
10/12/2011	CN102212138A Tubercle bacillus fusion protein HspX-Mtb8.4 and preparation method and application thereof
10/12/2011	CN102212137A Genetically engineered recombinant polypeptide for cloven-hoofed animals
10/12/2011	CN102210860A Mycobacterium tuberculosis TB10.4-F1 fusion protein vaccine and preparation method thereof
10/12/2011	CN102210859A Mycobacterium tuberculosis ESAT-6-F2 fusion protein subunit vaccine and preparation method thereof
10/12/2011	CN101433713B GnRH-PE mutant fusion protein and uses thereof
10/11/2011	US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents
10/11/2011	US8034784 Method of suppressing or reducing IL-TIF-induced inflammation, or treating associated conditions thereof, using Zcytor16
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	CA2447538C Cellular signal-responsive gene transcriptional regulation system
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/06/2011	WO2011123683A2 Protease activated cytokines
10/06/2011	WO2011120135A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011120134A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011077309A3 Vaccine compositions
10/06/2011	WO2011056911A3 Compositions and methods for enhancing production of a biological product
10/06/2011	WO2011036443A3 Si protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
10/06/2011	US20110245472 Method for the mass production of immunoglobulin constant region
10/06/2011	US20110245178 Exendin Fusion Proteins
10/06/2011	US20110245174 Glp-1 fusion polypeptides
10/06/2011	US20110244576 Herpes Simplex Virus Complex
10/06/2011	US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
10/06/2011	US20110244546 Internalizing Anti-CD74 Antibodies and Methods of Use
10/06/2011	US20110244513 Isolated mammalian membrane protein genes; related reagents
10/06/2011	US20110243972 Prostate stem cell antigen vaccines and uses thereof
10/06/2011	US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO
10/06/2011	US20110243944 Fusion Protein Inhibiting Osteoclast Formation, Preparation Method and Medicine Compositions Thereof
10/06/2011	US20110243942 Relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243912 Growth Factor Binding Constructs Materials and Methods
10/06/2011	US20110243887 Il-7 fusion proteins
10/06/2011	US20110243849 Heme-binding photoactive polypeptides and methods of use thereof
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	DE102010013887A1 Fusionsprotein und dessen Verwendungen Fusion protein and uses thereof
10/06/2011	CA2698413A1 Rotavirus vaccine
10/05/2011	EP2371953A1 Fluorescent protein
10/05/2011	EP2370473A2 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/05/2011	EP2370470A1 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
10/05/2011	EP1971684B1 Chimaeric fusion protein with superior chaperone and folding activities
10/05/2011	EP0975762B1 Type-1 ribosome-inactivating protein
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102206660A Engineered protein TAT-VP28 against white spot syndrome virus of shrimp and its preparation and purpose
10/05/2011	CN102206285A Chimeric peptide based on endomorphins 2 and neuropeptides FF, and synthesis and application thereof
10/05/2011	CN102206284A Recombinant human DT388sBAFF immunotoxin and coding gene and use thereof
10/05/2011	CN102206283A Recombinant human PE38sBAFF immunotoxin and coding gene and use thereof
10/05/2011	CN102206282A Efficient method for producing Trx-hCTRP2
10/05/2011	CN102206281A Fusion protein TETPH, expression vector and construction method thereof
10/05/2011	CN101270361B Japanese blood fluke TSP protein extracellular cyclo-2 encoding gene, polypeptide, amalgamation protein and uses in preparing vaccine
10/05/2011	CN101240033B Fusion protein of insulin secretion accelerating peptide and human serum albumin, and preparation method thereof
10/05/2011	CN101148662B Heterogenous expression and purifying method for human AIDS virus auxiliary receptor CCR5
10/04/2011	US8030468 Human T2R51 taste receptor nucleic acid sequences and polypeptides
10/04/2011	US8030456 Nogo receptor antagonists

1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 295